Trial Profile
A randomised control trial of 5-Aminolevulinic Acid in combination with Sodium Ferrous Citrate to Enhance Cardioprotection in Adults undergoing Cardiac Surgery
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary) ; Sodium ferrous citrate (Primary)
- Indications Low cardiac output; Myocardial reperfusion injury
- Focus Therapeutic Use
- 16 Mar 2017 New trial record